BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 37040432)

  • 1. Efficacy and safety of low levels of low-density lipoprotein cholesterol: trans-ancestry linear and non-linear Mendelian randomization analyses.
    Liu H; Li J; Liu F; Huang K; Cao J; Chen S; Li H; Shen C; Hu D; Huang J; Lu X; Gu D
    Eur J Prev Cardiol; 2023 Sep; 30(12):1207-1215. PubMed ID: 37040432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating linear and nonlinear associations of LDL cholesterol with incident chronic kidney disease, atherosclerotic cardiovascular disease and all-cause mortality: A prospective and Mendelian randomization study.
    Wang Z; Xiao Y; Lu J; Zou C; Huang W; Zhang J; Liu S; Han L; Jiao F; Tian D; Jiang Y; Du X; Ma RCW; Jiang G
    Atherosclerosis; 2023 Dec; 387():117394. PubMed ID: 38029611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Joint Genetic Inhibition of PCSK9 and CETP and the Association With Coronary Artery Disease: A Factorial Mendelian Randomization Study.
    Cupido AJ; Reeskamp LF; Hingorani AD; Finan C; Asselbergs FW; Hovingh GK; Schmidt AF
    JAMA Cardiol; 2022 Sep; 7(9):955-964. PubMed ID: 35921096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Determinants of Lipids and Cardiovascular Disease Outcomes: A Wide-Angled Mendelian Randomization Investigation.
    Allara E; Morani G; Carter P; Gkatzionis A; Zuber V; Foley CN; Rees JMB; Mason AM; Bell S; Gill D; Lindström S; Butterworth AS; Di Angelantonio E; Peters J; Burgess S;
    Circ Genom Precis Med; 2019 Dec; 12(12):e002711. PubMed ID: 31756303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appraising associations between signature lipidomic biomarkers and digestive system cancer risk: novel evidences from a prospective cohort study of UK Biobank and Mendelian randomization analyses.
    Sun Y; Cao D; Zhang Y; Wu Y; Jia Z; Cui Y; Li D; Cao X; Jiang J
    Lipids Health Dis; 2024 Feb; 23(1):61. PubMed ID: 38419059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-density lipoprotein cholesterol and risk of hepatocellular carcinoma: a Mendelian randomization and mediation analysis.
    Cao J; Wang Z; Zhu M; Huang Y; Jin Z; Xiong Z
    Lipids Health Dis; 2023 Jul; 22(1):110. PubMed ID: 37525197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-Response Associations of Lipid Traits With Coronary Artery Disease and Mortality.
    Yang G; Mason AM; Wood AM; Schooling CM; Burgess S
    JAMA Netw Open; 2024 Jan; 7(1):e2352572. PubMed ID: 38241044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Traits and Stroke Risk in Individuals of African Ancestry: Mendelian Randomization Analysis.
    Fatumo S; Karhunen V; Chikowore T; Sounkou T; Udosen B; Ezenwa C; Nakabuye M; Soremekun O; Daghlas I; Ryan DK; Taylor A; Mason AM; Damrauer SM; Vujkovic M; Keene KL; Fornage M; Järvelin MR; Burgess S; Gill D
    Stroke; 2021 Aug; 52(8):2680-2684. PubMed ID: 34078102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive Effects of Genetic Interleukin-6 Signaling Downregulation and Low-Density Lipoprotein Cholesterol Lowering on Cardiovascular Disease: A 2×2 Factorial Mendelian Randomization Analysis.
    Georgakis MK; Malik R; Burgess S; Dichgans M
    J Am Heart Assoc; 2022 Jan; 11(1):e023277. PubMed ID: 34927447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causal role of lipid metabolome on the risk of ischemic stroke, its etiological subtypes, and long-term outcome: A Mendelian randomization study.
    Martín-Campos JM; Cárcel-Márquez J; Llucià-Carol L; Lledós M; Cullell N; Muiño E; Gallego-Fabrega C; Fernández-Cadenas I
    Atherosclerosis; 2023 Dec; 386():117382. PubMed ID: 38006695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent Causal Effect of Remnant Cholesterol on Atherosclerotic Cardiovascular Outcomes: A Mendelian Randomization Study.
    Navarese EP; Vine D; Proctor S; Grzelakowska K; Berti S; Kubica J; Raggi P
    Arterioscler Thromb Vasc Biol; 2023 Sep; 43(9):e373-e380. PubMed ID: 37439258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct metabolic features of genetic liability to type 2 diabetes and coronary artery disease: a reverse Mendelian randomization study.
    Smith ML; Bull CJ; Holmes MV; Davey Smith G; Sanderson E; Anderson EL; Bell JA
    EBioMedicine; 2023 Apr; 90():104503. PubMed ID: 36870196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Genetically Predicted Lipid Levels With the Extent of Coronary Atherosclerosis in Icelandic Adults.
    Björnsson E; Thorleifsson G; Helgadóttir A; Guðnason T; Guðbjartsson T; Andersen K; Grétarsdóttir S; Ólafsson Í; Tragante V; Ólafsson ÓH; Jónsdóttir B; Eyjólfsson GI; Sigurðardóttir Ó; Thorgeirsson G; Guðbjartsson DF; Thorsteinsdóttir U; Hólm H; Stefánsson K
    JAMA Cardiol; 2020 Jan; 5(1):13-20. PubMed ID: 31746962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of metabolic risk factors and lifestyle behaviors to cardiovascular disease: A mendelian randomization study.
    Jia Y; Wang R; Guo D; Sun L; Shi M; Zhang K; Yang P; Zang Y; Wang Y; Liu F; Zhang Y; Zhu Z
    Nutr Metab Cardiovasc Dis; 2022 Aug; 32(8):1972-1981. PubMed ID: 35610082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically-predicted life-long lowering of low-density lipoprotein cholesterol is associated with decreased frailty: A Mendelian randomization study in UK biobank.
    Wang Q; Wang Y; Lehto K; Pedersen NL; Williams DM; Hägg S
    EBioMedicine; 2019 Jul; 45():487-494. PubMed ID: 31300347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholesterol not particle concentration mediates the atherogenic risk conferred by apolipoprotein B particles: a Mendelian randomization analysis.
    Helgadottir A; Thorleifsson G; Snaebjarnarson A; Stefansdottir L; Sveinbjornsson G; Tragante V; Björnsson E; Steinthorsdottir V; Gretarsdottir S; Helgason H; Saemundsdottir J; Olafsson I; Thune JJ; Raja AA; Ghouse J; Olesen MS; Christensen A; Jacobsen RL; Dowsett J; Bruun MT; Nielsen K; Knowlton K; Nadauld L; Benediktsson R; Erikstrup C; Pedersen OB; Banasik K; Brunak S; ; Bundgaard H; Ostrowski SR; Sulem P; Arnar DO; Thorgeirsson G; Thorsteinsdottir U; Gudbjartsson DF; Stefansson K; Holm H
    Eur J Prev Cardiol; 2022 Dec; 29(18):2374-2385. PubMed ID: 36125206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mendelian randomization studies in coronary artery disease.
    Jansen H; Samani NJ; Schunkert H
    Eur Heart J; 2014 Aug; 35(29):1917-24. PubMed ID: 24917639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic associations of adult height with risk of cardioembolic and other subtypes of ischemic stroke: A mendelian randomization study in multiple ancestries.
    Linden AB; Clarke R; Hammami I; Hopewell JC; Guo Y; Whiteley WN; Lin K; Turnbull I; Chen Y; Yu C; Lv J; Offer A; Bennett D; Walters RG; Li L; Chen Z; Parish S;
    PLoS Med; 2022 Apr; 19(4):e1003967. PubMed ID: 35452448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic proxies for PCSK9 inhibition associate with lipoprotein(a): Effects on coronary artery disease and ischemic stroke.
    De Marchis GM; Dittrich TD; Malik R; Zietz AV; Kriemler LF; Ference BA; Dichgans M; Georgakis MK
    Atherosclerosis; 2022 Nov; 361():41-46. PubMed ID: 36244797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Bile Acid Sequestrants on the Risk of Cardiovascular Events: A Mendelian Randomization Analysis.
    Ross S; D'Mello M; Anand SS; Eikelboom J; ; Stewart AF; Samani NJ; Roberts R; Paré G
    Circ Cardiovasc Genet; 2015 Aug; 8(4):618-27. PubMed ID: 26043746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.